Breaking News Instant updates and real-time market news.

2020-11-20 15:49:19 DTIL Precision BioSciences $10.75 / +1.12 (+11.63%) , LLY Eli Lilly $144.88 / +1.42 (+0.99%) 15:49 11/20/20 11/20 15:49 11/20/20 15:49	Precision BioSciences price target raised to $22 from $21 at Stifel Stifel analyst Benjamin Burnett raised the firm's price target on Precision BioSciences (DTIL) to $22 from $21 and keeps a Buy rating on the shares following the company announcing a genome editing collaboration with Eli Lilly (LLY). The analyst believes this "brings outside validation for what [he thinks] is an often overlooked aspect of the business," and also comes with an upfront cash infusion of $135M, as well as $420M in potential milestones. DTIL Precision BioSciences $10.75 / +1.12 (+11.63%) LLY Eli Lilly $144.88 / +1.42 (+0.99%)	23 Nov 05 Dec 15 Dec 29 Jan
DTIL LLY DTIL Precision BioSciences $10.75 / +1.12 (+11.63%) 10/21/20 Stifel Crispr Therapeutics price target raised to $93 from $75 at Stifel 07/27/20 BTIG Precision BioSciences assumed with a Buy at BTIG 05/18/20 H.C. Wainwright Precision BioSciences could have 'significant upside,' says H.C. Wainwright 04/02/20 Goldman Sachs Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs LLY Eli Lilly $144.88 / +1.42 (+0.99%) 11/17/20 Mizuho Eli Lilly price target lowered to $156 from $164 at Mizuho 11/10/20 Bernstein Eli Lilly initiated with a Market Perform, $150 price target at Bernstein 11/10/20 Bernstein Eli Lilly initiated with a Market Perform at Bernstein 11/10/20 SVB Leerink Regeneron price target lowered to $643 from $653 at SVB Leerink

2020-11-20 15:49:19

DTIL

Precision BioSciences

$10.75 / +1.12 (+11.63%)

, LLY

Eli Lilly

$144.88 / +1.42 (+0.99%)

15:49

11/20/20

11/20

15:49

11/20/20

15:49

Precision BioSciences price target raised to $22 from $21 at Stifel

Stifel analyst Benjamin Burnett raised the firm's price target on Precision BioSciences (DTIL) to $22 from $21 and keeps a Buy rating on the shares following the company announcing a genome editing collaboration with Eli Lilly (LLY). The analyst believes this "brings outside validation for what [he thinks] is an often overlooked aspect of the business," and also comes with an upfront cash infusion of $135M, as well as $420M in potential milestones.

DTIL

Precision BioSciences

$10.75 / +1.12 (+11.63%)

LLY

Eli Lilly

$144.88 / +1.42 (+0.99%)

23
Nov
05
Dec
15
Dec
29
Jan

DTIL
LLY

DTIL Precision BioSciences

$10.75 / +1.12 (+11.63%)

10/21/20 Stifel: Crispr Therapeutics price target raised to $93 from $75 at Stifel

07/27/20 BTIG: Precision BioSciences assumed with a Buy at BTIG

05/18/20 H.C. Wainwright: Precision BioSciences could have 'significant upside,' says H.C. Wainwright

04/02/20 Goldman Sachs: Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs

LLY Eli Lilly

$144.88 / +1.42 (+0.99%)

11/17/20 Mizuho: Eli Lilly price target lowered to $156 from $164 at Mizuho

11/10/20 Bernstein: Eli Lilly initiated with a Market Perform, $150 price target at Bernstein

11/10/20 Bernstein: Eli Lilly initiated with a Market Perform at Bernstein

11/10/20 SVB Leerink: Regeneron price target lowered to $643 from $653 at SVB Leerink

TODAY'S FREE FLY STORIES

Upgrade	Silgan Holdings double-upgraded to Buy at BofA on demand strength » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) BofA analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 01/26/21 Silgan Holdings jumps 3% to $37.45 after Q4 earnings beat 08/28/20 Silgan Holdings' Horrigan sells 800,000 common shares 08/28/20 Silgan Holdings' Snyder sells over 24,000 common shares SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 06:05 Today BofA Silgan Holdings upgraded to Buy from Underperform at BofA 01/07/21 Citi Silgan Holdings downgraded to Neutral from Buy at Citi 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo SLGN Silgan Holdings $35.87 / -0.42 (-1.16%) 01/26/21 Silgan Holdings guides FY21 EPS $3.30-$3.45, consensus $3.08 01/26/21 Silgan Holdings reports Q4 EPS 60c, consensus 53c 10/21/20 Silgan Holdings raises FY20 adj. EPS view to $2.92-$2.97 from $2.70-$2.85 10/21/20 Silgan Holdings sees Q4 adj. EPS 47c-52c, consensus 49c
Syndicate	Qualtrics 50.4M share IPO priced at $30.00 » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 XM Qualtrics $0.00 / + (+0.00%) The deal priced above the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 28 Jan XM Qualtrics $0.00 / + (+0.00%) 01/24/21 Opening Day: Mytheresa raises $407M in U.S. market debut 01/17/21 Opening Day: Poshmark surges in debut, PetCo soars in return to market 01/10/21 Opening Day: Cullinan, Gracell surge in debut as SPAC craze continues 12/29/20 Fly Intel: Pre-market Movers
Initiation	Monopar Therapeutics initiated with a Buy at Roth Capital » 06:14 01/28/21 01/28 06:14 01/28/21 06:14 MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 12/22/20 Monopar Therapeutics announces issuance of U.S. patent for camsirubicin analogs 12/10/20 Monopar Therapeutics, NorthStar announce selection of uPRIT candidate 12/08/20 Monopar Therapeutics intiates Phase 2b/3 trial of Validive 11/09/20 Monopar announces issuance of new patents for Validive MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 09/24/20 Maxim Monopar Therapeutics initiated with a Buy at Maxim 06/16/20 JonesTrading JonesTrading backs Buy on Monoper after NorthStar Medical collaboration 02/19/20 Brookline Monopar Therapeutics initiated with a Buy at Brookline 02/03/20 JonesTrading Monopar Therapeutics initiated with a Buy at JonesTrading MNPR Monopar Therapeutics $6.60 / -0.25 (-3.65%) 11/12/20 Monopar Therapeutics reports Q3 EPS (15c), consensus (15c)
Hot Stocks	New York Times names Cliff Levy to oversee audio unit » 06:12 01/28/21 01/28 06:12 01/28/21 06:12 NYT New York Times $55.00 / -1.285 (-2.28%) The New York Times… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NYT New York Times $55.00 / -1.285 (-2.28%) 01/19/21 Wright's Media announces collaboration with New York Times' Wirecutter 11/17/20 New York Times appoints Jacqueline Welch as EVP, CHRO 11/05/20 New York Times sees Q4 total subscription revenues up 14% 10/13/20 New York Times reduces pension obligations by $235M NYT New York Times $55.00 / -1.285 (-2.28%) 11/09/20 Evercore ISI New York Times upgraded to Outperform from In Line at Evercore ISI 10/27/20 JPMorgan New York Times selloff brings attractive entry point, says JPMorgan 10/14/20 Fly Intel: Top five analyst initiations 10/14/20 Morgan Stanley New York Times initiated with an Overweight at Morgan Stanley NYT New York Times $55.00 / -1.285 (-2.28%) 11/05/20 New York Times reports Q3 adj. EPS 22c, consensus 11c 08/05/20 New York Times reports Q2 adj. EPS 18c, consensus 1c NYT New York Times $55.00 / -1.285 (-2.28%) 09/16/20 Facebook, New York Times partner on AR reporting project, Axios reports 08/20/20 More companies join fight against Apple App Store terms, WSJ says NYT New York Times $55.00 / -1.285 (-2.28%) 08/25/20 Game On: Apple-Epic legal spat continues as Microsoft's Spencer weighs in 02/04/21 New York Times - NYT
Recommendations	TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 11/09/20 TherapeuticsMD begins process to divest vitaCare Prescription Services 09/21/20 TherapeuticsMD, Knight announces Health Canada approval of BIJUVA 09/09/20 TherapeuticsMD announces patent updates for Annovera 08/25/20 TherapeuticsMD, Knight Therapeutics announce Health Canada approval of IMVEXXY TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 08/07/20 Jefferies Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform 08/07/20 Jefferies TherapeuticsMD downgraded to Underperform from Hold at Jefferies 05/19/20 Fly Intel: Top five analyst downgrades 05/19/20 JPMorgan TherapeuticsMD downgraded to Neutral on COVID disruptions at JPMorgan TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 11/09/20 TherapeuticsMD reports Q3 EPS (12c) with items, consensus (14c) 09/25/20 TherapeuticsMD says on track to meet or exceed Q3 revenue consensus of $15.1M 08/06/20 TherapeuticsMD reports Q2 EPS (19c) with items, consensus (17c) 10 Nov TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 08/07/20 FedEx named Best Idea among today's top calls on Wall Street 03/01/21 41st Annual Healthcare Virtual Conference TXMD TherapeuticsMD $1.59 / +0.055 (+3.58%) 10/27/20 Largest borrow rate increases among liquid names 10/06/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names 08/12/20 Largest borrow rate increases among liquid names

Hot Stocks	United Therapeutics announces BREEZE study of Tyvaso meets primary endpoint » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 UTHR United Therapeutics $155.89 / -8.96 (-5.44%) United Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 01/27/21 3D Systems to expand efforts on regenerative medicine, bioprinting solutions 01/13/21 United Therapeutics: Results from INCREASE study of Tyvaso published in NEJM 12/28/20 Y-mAbs Therapeutics announces sale of priority review voucher 12/28/20 United Therapeutics to acquire PRV for Tyvaso DPI NDA UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 01/20/21 Oppenheimer United Therapeutics price target raised to $200 from $175 at Oppenheimer 01/20/21 Cowen United Therapeutics price target raised to $200 from $160 at Cowen 01/20/21 Ladenburg United Therapeutics price target raised to $199 from $151 at Ladenburg 01/19/21 Credit Suisse Insmed price target raised to $60 from $50 at Credit Suisse UTHR United Therapeutics $155.89 / -8.96 (-5.44%) 10/28/20 United Therapeutics reports Q3 EPS $3.84, consensus $2.78 07/29/20 United Therapeutics reports Q2 EPS $3.68, consensus $2.86
Recommendations	VBL Therapeutics price target raised to $4 from $3 at H.C. Wainwright » 06:11 01/28/21 01/28 06:11 01/28/21 06:11 VBLT VBL Therapeutics / + H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events VBLT VBL Therapeutics / + 01/27/21 VBL Therapeutics doses first patient in Phase 2 study of VB-201 01/15/21 VBL Therapeutics enters into share purchase agreement with Aspire Capital 12/29/20 VBL Therapeutics first patient for Oval Phase 3 study of VB-111 expansion 12/07/20 VBL Therapeutics chairman Bennett Shapiro purchases approx. 200K shares VBLT VBL Therapeutics / + 11/16/20 VBL Therapeutics reports Q3 EPS (12c), consensus (13c) 08/13/20 VBL Therapeutics reports Q2 EPS (14c), consensus (14c) VBLT VBL Therapeutics / + 12/30/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference
Upgrade	PTC upgraded to Outperform from Sector Perform at RBC Capital » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 PTC PTC $121.12 / -8.44 (-6.51%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PTC PTC $121.12 / -8.44 (-6.51%) 12/14/20 PTC to acquire Arena Solutions for $715M in cash 11/10/20 PTC names Troy Richardson as COO 10/28/20 PTC, Rockwell Automation extend strategic alliance 09/08/20 Teradata promotes Hillary Ashton to chief product officer PTC PTC $121.12 / -8.44 (-6.51%) 05:29 Today RBC Capital PTC upgraded to Outperform from Sector Perform at RBC Capital 01/21/21 Barclays PTC price target raised to $142 from $130 at Barclays 01/12/21 Mizuho PTC price target raised to $150 from $130 at Mizuho 12/21/20 Deutsche Bank PTC price target raised to $132 from $120 at Deutsche Bank PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 PTC reports Q1 EPS 97c, consensus 65c 01/27/21 PTC raises FY21 non-GAAP EPS view to $2.65-$2.85 from $3.05-$3.25 12/16/20 PTC Q1 ARR tracking to midpoint of $1.28B-$1.32B guidance range 10/28/20 PTC sees FY21 non-GAAP EPS $2.65-$2.85, consensus $2.83 PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 Fly Intel: After-Hours Movers 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 07/29/20 Fly Intel: After-Hours Movers 02/10/21 PTC Inc
Hot Stocks	Murphy Oil sees FY21 production 155-165 MBOEPD » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 MUR Murphy Oil $13.98 / +1.27 (+9.99%) Murphy is planning 2021… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MUR Murphy Oil $13.98 / +1.27 (+9.99%) 11/05/20 Murphy Oil backs 2020 CapEx view $680M-$720M MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/14/21 Scotiabank Murphy Oil upgraded to Sector Perform from Underperform at Scotiabank 01/11/21 Mizuho Murphy Oil price target raised to $18 from $10 at Mizuho 12/15/20 Wells Fargo Wells Fargo says Buy Exxon Mobil, Sell Murphy Oil in Oil & Gas ratings shake-up 12/15/20 Wells Fargo Murphy Oil downgraded to Underweight from Equal Weight at Wells Fargo MUR Murphy Oil $13.98 / +1.27 (+9.99%) 06:08 Today Murphy Oil reports Q4 adjusted EPS (9c), consensus (7c) 11/05/20 Murphy Oil sees Q4 total net production 146-154 MBOEPD excluding NCI 11/05/20 Murphy Oil reports Q3 adjusted EPS (15c), consensus (17c) 08/06/20 Murphy Oil reports Q2 adjusted EPS (71c), consensus (94c) MUR Murphy Oil $13.98 / +1.27 (+9.99%) 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 03/01/21 26th Annual Energy Virtual Summit 09:00 Today Murphy Oil - MUR MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/26/21 Murphy Oil put volume heavy and directionally bearish 01/19/21 Early notable gainers among liquid option names on January 19th 12/10/20 Early notable gainers among liquid option names on December 10th 12/08/20 Early notable gainers among liquid option names on December 8th
Hot Stocks	Barnwell Industries reaches pact with MRMP shareholders to end potential proxy » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 BRN Barnwell Industries $1.89 / -0.02 (-1.05%) Barnwell Industries is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< On The Fly BRN Barnwell Industries $1.89 / -0.02 (-1.05%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades

Recommendations	Celcuity price target raised to $18 from $14 at H.C. Wainwright » 06:10 01/28/21 01/28 06:10 01/28/21 06:10 CELC Celcuity $13.00 / -0.48 (-3.56%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CELC Celcuity $13.00 / -0.48 (-3.56%) 01/27/21 Celcuity announces trial collaboration with Pfizer, Sarah Cannon Research 12/23/20 Celcuity in clinical trial pact with with hospital and Puma Biotechnology CELC Celcuity $13.00 / -0.48 (-3.56%) 12/24/20 Craig-Hallum Celcuity price target raised to $19 from $16 at Craig-Hallum 12/24/20 H.C. Wainwright Celcuity price target raised to $14 from $11 at H.C. Wainwright 05/18/20 Craig-Hallum Celcuity assumed with a Buy at Craig-Hallum 05/11/20 Craig-Hallum Celcuity assumed with a Buy at Craig-Hallum
Periodicals	Pfizer study finds vaccine works against U.K., South Africa variants, WSJ says » 06:09 01/28/21 01/28 06:09 01/28/21 06:09 PFE Pfizer $35.87 / -1.05 (-2.84%) , BNTX BioNTech $106.00 / -0.29 (-0.27%) Findings from a Pfizer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/27/21 Celcuity announces trial collaboration with Pfizer, Sarah Cannon Research 01/27/21 Sanofi to provide support to BioNTech in manufacturing Covid vaccine 01/27/21 Pfizer: Xeljanz study in RA did not meet co-primary endpoints 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses BNTX BioNTech $106.00 / -0.29 (-0.27%) 01/27/21 Sanofi to provide support to BioNTech in manufacturing Covid vaccine 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 BioNTech, Shanghai Fosun receive Hong Kong approval for Covid vaccine PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $106.00 / -0.29 (-0.27%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $106.00 / -0.29 (-0.27%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/26/21 Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/25/21 Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says 01/25/21 Pfizer to ship fewer vaccine vials to fulfill commitment to U.S., NY Times says 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports BNTX BioNTech $106.00 / -0.29 (-0.27%) 01/26/21 Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $106.00 / -0.29 (-0.27%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $35.87 / -1.05 (-2.84%) 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th BNTX BioNTech $106.00 / -0.29 (-0.27%) 01/26/21 BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th
Upgrade	Central Pacific upgraded to Overweight from Neutral at Piper Sandler » 06:08 01/28/21 01/28 06:08 01/28/21 06:08 CPF Central Pacific $18.65 / -0.87 (-4.46%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings CPF Central Pacific $18.65 / -0.87 (-4.46%) 06:00 Today Piper Sandler Central Pacific upgraded to Overweight from Neutral at Piper Sandler 06/10/20 Piper Sandler Central Pacific assumed with a Neutral at Piper Sandler 04/23/20 Compass Point Central Pacific upgraded to Buy from Neutral at Compass Point 04/23/20 Compass Point Central Pacific upgraded to Buy from Neutral at Compass Point CPF Central Pacific $18.65 / -0.87 (-4.46%) 01/27/21 Central Pacific reports Q4 EPS 43c, consensus 35c 10/28/20 Central Pacific reports Q3 EPS 24c, consensus 34c 07/29/20 Central Pacific reports Q2 EPS 35c, consensus 22c
Earnings	Murphy Oil reports Q4 adjusted EPS (9c), consensus (7c) » 06:08 01/28/21 01/28 06:08 01/28/21 06:08 MUR Murphy Oil $13.98 / +1.27 (+9.99%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MUR Murphy Oil $13.98 / +1.27 (+9.99%) 11/05/20 Murphy Oil backs 2020 CapEx view $680M-$720M MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/14/21 Scotiabank Murphy Oil upgraded to Sector Perform from Underperform at Scotiabank 01/11/21 Mizuho Murphy Oil price target raised to $18 from $10 at Mizuho 12/15/20 Wells Fargo Wells Fargo says Buy Exxon Mobil, Sell Murphy Oil in Oil & Gas ratings shake-up 12/15/20 Wells Fargo Murphy Oil downgraded to Underweight from Equal Weight at Wells Fargo MUR Murphy Oil $13.98 / +1.27 (+9.99%) 11/05/20 Murphy Oil sees Q4 total net production 146-154 MBOEPD excluding NCI 11/05/20 Murphy Oil reports Q3 adjusted EPS (15c), consensus (17c) 08/06/20 Murphy Oil reports Q2 adjusted EPS (71c), consensus (94c) MUR Murphy Oil $13.98 / +1.27 (+9.99%) 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 03/01/21 26th Annual Energy Virtual Summit 09:00 Today Murphy Oil - MUR MUR Murphy Oil $13.98 / +1.27 (+9.99%) 01/26/21 Murphy Oil put volume heavy and directionally bearish 01/19/21 Early notable gainers among liquid option names on January 19th 12/10/20 Early notable gainers among liquid option names on December 10th 12/08/20 Early notable gainers among liquid option names on December 8th
Downgrade	Albertsons downgraded to In Line from Outperform at Evercore ISI » 06:07 01/28/21 01/28 06:07 01/28/21 06:07 ACI Albertsons $20.47 / +0.97 (+4.97%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACI Albertsons $20.47 / +0.97 (+4.97%) 11/30/20 Albertsons associates ratify agreement with UFCW local unions 11/24/20 Albertsons implements contactless temperature, health screening 11/19/20 Albertsons incorporates SNAP EBT payments at Drive Up & Go locations 11/12/20 Albertsons to partner with HHS to provide COVID-19 vaccine ACI Albertsons $20.47 / +0.97 (+4.97%) 01/27/21 Fly Intel: Top five analyst downgrades 01/27/21 Wells Fargo Albertsons downgraded to Equal Weight from Overweight at Wells Fargo 01/20/21 Morgan Stanley Albertsons downgraded to Underweight with $13 price target at Morgan Stanley 01/20/21 Morgan Stanley Kroger downgraded to Underweight at Morgan Stanley ACI Albertsons $20.47 / +0.97 (+4.97%) 01/12/21 Albertsons raises FY20 adjusted EPS view to $3.05-$3.15 from $2.75-$2.85 01/12/21 Albertsons reports Q3 adjusted EPS 66c, consensus 42c 01/11/21 Notable companies reporting before tomorrow's open 01/11/21 Notable companies reporting before tomorrow's open 26 Jun ACI Albertsons $20.47 / +0.97 (+4.97%) 01/21/21 Biden poised to freeze oil, coal leasing on federal land, Bloomberg says 09/19/20 Albertsons a Buy as stock looks cheap, Barron's says ACI Albertsons $20.47 / +0.97 (+4.97%) 01/12/21 Fly Intel: Pre-market Movers 11/09/20 Fly Intel: What to watch in Beyond Meat earnings report 10/20/20 Fly Intel: Pre-market Movers 10/14/20 Fly Intel: After-Hours Movers ACI Albertsons $20.47 / +0.97 (+4.97%) 01/13/21 Largest borrow rate increases among liquid names 01/12/21 Largest borrow rate increases among liquid names 01/11/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names

Hot Stocks	MiX Telematics suspends FY21 guidance » 06:07 01/28/21 01/28 06:07 01/28/21 06:07 MIXT MiX Telematics $13.60 / -0.21 (-1.52%) Due to the uncertainty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 12/10/20 MiX Telematics announces Translink renews contract 09/24/20 MiX Telematics announces partnership agreement with Navistar MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 05/29/20 Canaccord MiX Telematics price target lowered to $18 from $30 at Canaccord 03/09/20 First Analysis First Analysis downgrades MiX Telematics to Outperform on energy exposure 03/09/20 First Analysis MiX Telematics downgraded to Outperform from Strong Buy at First Analysis MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 06:06 Today MiX Telematics reports Q3 adjusted EPS 15c, consensus 3c 10/29/20 MiX Telematics reports Q2 EPS 20c, consensus 2c 07/30/20 MiX Telematics reports Q1 non-GAAP EPS 8c, consensus (3c) 08:00 Today MiX Telematics - MIXT
Upgrade	Invesco upgraded to Buy from Neutral at UBS » 06:07 01/28/21 01/28 06:07 01/28/21 06:07 IVZ Invesco / + UBS analyst Brennan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options IVZ Invesco / + 01/12/21 Invesco reports preliminary AUM $1.349T as of December 31 12/09/20 Invesco reports preliminary AUM $1.294T as of November 30 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 11/09/20 Peltz 'thrilled' to be on Invesco board, 'didn't say' it should merge with Janus IVZ Invesco / + 01/27/21 BMO Capital Invesco price target raised to $22 from $19 at BMO Capital 01/27/21 Deutsche Bank Invesco price target raised to $27 from $25 at Deutsche Bank 01/25/21 Barclays Invesco price target raised to $18 from $15 at Barclays 01/15/21 Evercore ISI Invesco removed from 'Tactical Outperform list' at Evercore ISI IVZ Invesco / + 01/26/21 Invesco reports Q4 adjusted EPS 72c, consensus 57c 10/27/20 Invesco reports Q3 adj. EPS 53c, consensus 47c 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open IVZ Invesco / + 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 11/19/20 Janus Henderson working with Centerview on activist defense, Dealreporter says 11/05/20 Invesco CEO says no discussion with Janus Henderson, Barron's reports IVZ Invesco / + 10/27/20 Fly Intel: Pre-market Movers 10/02/20 Fly Intel: Wall Street's top stories for Friday 10/02/20 Fly Intel: Wall Street's top stories at midday 10/02/20 Fly Intel: Pre-market Movers IVZ Invesco / + 01/20/21 Early notable gainers among liquid option names on January 20th 12/30/20 Invesco put volume heavy and directionally bearish 10/08/20 Early notable gainers among liquid option names on October 8th 10/05/20 Unusually active option classes on open October 5th
Earnings	MiX Telematics reports Q3 adjusted EPS 15c, consensus 3c » 06:06 01/28/21 01/28 06:06 01/28/21 06:06 MIXT MiX Telematics $13.60 / -0.21 (-1.52%) Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 12/10/20 MiX Telematics announces Translink renews contract 09/24/20 MiX Telematics announces partnership agreement with Navistar MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 05/29/20 Canaccord MiX Telematics price target lowered to $18 from $30 at Canaccord 03/09/20 First Analysis First Analysis downgrades MiX Telematics to Outperform on energy exposure 03/09/20 First Analysis MiX Telematics downgraded to Outperform from Strong Buy at First Analysis MIXT MiX Telematics $13.60 / -0.21 (-1.52%) 10/29/20 MiX Telematics reports Q2 EPS 20c, consensus 2c 07/30/20 MiX Telematics reports Q1 non-GAAP EPS 8c, consensus (3c) 08:00 Today MiX Telematics - MIXT
Upgrade	Investar Holding upgraded to Overweight from Neutral at Piper Sandler » 06:06 01/28/21 01/28 06:06 01/28/21 06:06 ISTR Investar Holding / + Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ISTR Investar Holding / + 01/25/21 Investar Holding acquires Cheaha Financial Group for $41.1M 09/23/20 Investar Holding raises quarterly dividend 8% to 6.5c per share 08/27/20 Investar Holding authorizes extension of share repurchase program ISTR Investar Holding / + 06:00 Today Piper Sandler Investar Holding upgraded to Overweight from Neutral at Piper Sandler 09/15/20 Fly Intel: Top analyst downgrades 09/15/20 DA Davidson Investar Holding downgraded to Neutral from Buy at DA Davidson 06/17/20 Raymond James Investar Holding downgraded to Market Perform from Outperform at Raymond James ISTR Investar Holding / + 01/25/21 Investar Holding reports Q4EPS 39c, consensus 10/22/20 Investar Holding reports Q3 non-GAAP EPS 35c, consensus 29c
Downgrade	Colgate-Palmolive downgraded to Hold from Buy at Stifel » 06:06 01/28/21 01/28 06:06 01/28/21 06:06 CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) Stifel analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) 10/30/20 Colgate-Palmolive CFO Henning Jakobsen to retire, Stanley Sutula to succeed 10/30/20 Colgate-Palmolive reports Q3 adjusted gross profit margin 61.2%, up 220 bps 10/30/20 Colgate-Palmolive CEO says 'better visibility for the balance of the year' 07/31/20 Colgate-Palmolive reports Q2 base business gross profit margin 60.8% CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) 01/26/21 Berenberg Colgate-Palmolive upgraded to Hold from Sell at Berenberg 01/19/21 Bernstein Colgate-Palmolive initiated with an Underperform at Bernstein 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 01/04/21 Fly Intel: Top five analyst downgrades CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) 10/30/20 Colgate-Palmolive sees FY20 revenue 'up mid-single digits,' consensus $16B 10/30/20 Colgate-Palmolive reports Q3 adjusted EPS 79c, consensus 70c 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 12/08/20 Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street 10/30/20 Fly Intel: Pre-market Movers 01/29/21 Colgate-Palmolive - CL CL Colgate-Palmolive $78.09 / -0.66 (-0.84%) 09/01/20 Colgate Palmolive put volume heavy and directionally bearish

Downgrade	Procter & Gamble downgraded to Hold from Buy at Stifel » 06:06 01/28/21 01/28 06:06 01/28/21 06:06 PG Procter & Gamble $128.41 / -4.66 (-3.50%) Stifel analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PG Procter & Gamble $128.41 / -4.66 (-3.50%) 01/22/21 Procter & Gamble licenses nasal swab to Rhinostics for Covid test 01/21/21 Cerner appoints Marck Erceg as CFO 01/20/21 Procter & Gamble says innovating, bringing new products to market 01/20/21 Procter & Gamble says strong momentum continued in Q2 PG Procter & Gamble $128.41 / -4.66 (-3.50%) 01/19/21 Bernstein Procter & Gamble initiated with a Market Perform at Bernstein 01/13/21 Deutsche Bank Procter & Gamble price target raised to $159 from $156 at Deutsche Bank 01/06/21 Evercore ISI PepsiCo downgraded to In Line to reflect macro view at Evercore ISI 12/07/20 Wells Fargo Colgate-Palmolive initiated with an Underweight at Wells Fargo PG Procter & Gamble $128.41 / -4.66 (-3.50%) 01/20/21 Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% 01/20/21 Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open PG Procter & Gamble $128.41 / -4.66 (-3.50%) 11/13/20 Procter & Gamble new disinfectant on pace for $200M in sales, WSJ reports 10/13/20 P&G investors approve proposal for deforestation report, Bloomberg says PG Procter & Gamble $128.41 / -4.66 (-3.50%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street PG Procter & Gamble $128.41 / -4.66 (-3.50%) 12/09/20 Notable open interest changes for December 9th 10/20/20 Unusually active option classes on open October 20th
Upgrade	Silgan Holdings upgraded to Buy from Underperform at BofA » 06:05 01/28/21 01/28 06:05 01/28/21 06:05 SLGN Silgan Holdings / + BofA analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SLGN Silgan Holdings / + 01/26/21 Silgan Holdings jumps 3% to $37.45 after Q4 earnings beat 08/28/20 Silgan Holdings' Horrigan sells 800,000 common shares 08/28/20 Silgan Holdings' Snyder sells over 24,000 common shares SLGN Silgan Holdings / + 01/07/21 Citi Silgan Holdings downgraded to Neutral from Buy at Citi 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo 12/04/20 Wells Fargo Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo 12/03/20 KeyBanc Silgan Holdings upgraded to Overweight at KeyBanc SLGN Silgan Holdings / + 01/26/21 Silgan Holdings guides FY21 EPS $3.30-$3.45, consensus $3.08 01/26/21 Silgan Holdings reports Q4 EPS 60c, consensus 53c 10/21/20 Silgan Holdings raises FY20 adj. EPS view to $2.92-$2.97 from $2.70-$2.85 10/21/20 Silgan Holdings sees Q4 adj. EPS 47c-52c, consensus 49c
Recommendations	Commvault price target raised to $70 from $68 at Piper Sandler » 06:05 01/28/21 01/28 06:05 01/28/21 06:05 CVLT Commvault / + Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CVLT Commvault / + 01/27/21 Commvault expects FY23 recurring revenue to approach 80%-85% of total revenue 01/27/21 Commvault says on path to deliver over 25% EBITDA through FY23 10/27/20 Commvault says ransomware 'top of mind' with customers 10/27/20 Commvault sees 'cloud-first' strategy leading return to growth CVLT Commvault / + 01/25/21 Needham Commvault price target raised to $66 from $60 at Needham 01/13/21 KeyBanc Commvault upgraded to Overweight on upcoming catalysts at KeyBanc 01/13/21 KeyBanc Commvault upgraded to Overweight from Sector Weight at KeyBanc 01/12/21 Piper Sandler Commvault upgraded to Overweight from Neutral at Piper Sandler CVLT Commvault / + 01/27/21 Commvault sees 2021 EPS $2.00, consensus $1.90 01/27/21 Commvault sees Q4 EPS 46c, consensus 47c 01/27/21 Commvault reports Q3 non-GAAP EPS 57c, consensus 47c 10/27/20 Commvault sees Q3 revenue $174M-$176M, consensus $172.9M
Downgrade	Big Lots downgraded to Hold from Buy at Loop Capital » 06:05 01/28/21 01/28 06:05 01/28/21 06:05 BIG Big Lots / + Loop Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BIG Big Lots / + 01/13/21 Big Lots falls -7.1% 01/13/21 Big Lots falls -8.6% 12/04/20 Big Lots falls -8.8% 12/04/20 Big Lots falls -9.6% BIG Big Lots / + 01/14/21 Loop Capital Big Lots price target lowered to $60 from $65 at Loop Capital 01/14/21 Deutsche Bank Big Lots price target lowered to $46 from $53 at Deutsche Bank 01/07/21 Barclays Big Lots downgraded to Underweight from Equal Weight at Barclays 01/04/21 JPMorgan Big Lots price target lowered to $53 from $55 at JPMorgan BIG Big Lots / + 01/13/21 Big Lots sees Q4 diluted EPS $2.40-$2.50, consensus $3.02 12/04/20 Big Lots reports Q3 adjusted EPS 76c, consensus 66c 09/29/20 Big Lots sees Q3 EPS 50c-70c, consensus 21c 08/28/20 Big Lots not reinstating full year guidance BIG Big Lots / + 08/17/20 Big Lots leaseback deal stopped Apollo takeover negotiations, Bloomberg says 08/17/20 Big Lots leaseback deal stopped Apollo takeover negotiations, Bloomberg says BIG Big Lots / + 12/04/20 Fly Intel: Pre-market Movers 09/29/20 Fly Intel: Pre-market Movers BIG Big Lots / + 08/14/20 Big Lots call volume above normal and directionally bullish
Periodicals	IDC estimates Apple shipped 90.1M phones during Q1, CNBC reports » 06:05 01/28/21 01/28 06:05 01/28/21 06:05 AAPL Apple $142.14 / -1.03 (-0.72%) Apple doesn't… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple says new Mac chip boosting line growth rate 01/27/21 Facebook says business and community were strong in Q4 01/27/21 Apple says Q1 results were strong in China 01/27/21 Apple says iPhone 12 Pro and Pro Max did especially well in Q1 AAPL Apple $142.14 / -1.03 (-0.72%) 01/26/21 Credit Suisse Credit Suisse could see software, battery as key underpinnings of Apple car 01/25/21 Morgan Stanley Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value 01/25/21 Evercore ISI Evercore ISI raises Apple price target to $160, sees higher odds of car product 01/25/21 Raymond James Apple price target raised to $150 from $140 at Raymond James AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple to accelerate production shift outside China, Nikkei Asia says 01/25/21 Apple sued in Italy over throttled iPhone 6 devices, TechCrunch says 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Foxconn said to receive extra iPhone 12 Pro orders, DigiTimes reports AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Fly Intel: After-Hours Movers 01/27/21 #SocialStocks: Eyes on Facebook ahead of Q4 results 01/27/21 Fly Intel: What to watch in Apple earnings report 01/27/21 Fly Intel: What to watch in Facebook earnings report 02/23/21 Apple, Inc. AAPL Apple $142.14 / -1.03 (-0.72%) 01/27/21 Apple options imply 10.6% move in share price post-earnings 01/26/21 Notable open interest changes for January 26th 01/25/21 Notable open interest changes for January 25th 01/22/21 Notable open interest changes for January 22nd

Events

Earnings calls, analyst events, roadshows and more

MMYT
Today at 07:30

MakeMyTrip - MMYT Conference Calls
MIXT
Today at 08:00

MiX Telematics - MIXT Conference Calls
MKC
Today at 08:00

McCormick - MKC Conference Calls
WHR
Today at 08:00

Whirlpool - WHR Conference Calls
NURO
Today at 08:00

NeuroMetrix - NURO Conference Calls
SLM
Today at 08:00

Sallie Mae - SLM Conference Calls
LSTR
Today at 08:00

Landstar System - LSTR Conference Calls
DHR
Today at 08:00

Danaher - DHR Conference Calls
DOW
Today at 08:00

Dow Inc. - DOW Conference Calls
FLWS
Today at 08:00

1-800-Flowers.com - FLWS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital Priced at: $10.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams Priced at: $17.00 76M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS Priced at: $18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL Priced at: $30.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA Priced at: $21.50 12M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGTC X AGTC Applied Genetic Spot Secondary Managers: Stifel, Wells Fargo & MTS Health Partners $4.45 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PWFL X PWFL PowerFleet Spot Secondary Managers: Canaccord $8.01
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Precision BioSciences price target raised to $22 from $21 at Stifel

TODAY'S FREE FLY STORIES

Get Full Fly Access